A FIRST‐IN‐HUMAN TRIAL OF THE NOVEL MULTI‐ACTION THERAPY TINOSTAMUSTINE (EDO‐S101) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) HODGKIN LYMPHOMA (HL). (12th June 2019) - Pinto, A.; De Filippi, R.; Zinzani, P.; Driessen, C.; Tun, H.W.; Hilgier, K.; Remmy, D.; Mehrling, T.; O'Connor, O.A.